Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James E Galvin

Showing results (1-10 of 286) with videos related to

Pageof 29
Sort By:
Prion|December 18, 2010
Dementia screening, biomarkers and protein misfolding: Implications for public health and diagnosisJames E Galvin
Acta Neuropathologica|June 23, 2006
Interaction of alpha-synuclein and dopamine metabolites in the pathogenesis of Parkinson's disease: a case for the selective vulnerability of the substantia nigraJames E Galvin
Continuum (Minneapolis, Minn.)|December 2, 2024
Lewy Body DementiaJames E Galvin
Archives of Neurology|September 17, 2003
Dementia with Lewy bodiesJames E Galvin
Alzheimer'S & Dementia (Amsterdam, Netherlands)|September 26, 2015
IMPROVING THE CLINICAL DETECTION OF LEWY BODY DEMENTIA WITH THE LEWY BODY COMPOSITE RISK SCOREJames E Galvin
Journal of the American Geriatrics Society|August 3, 2017
Prevention of Alzheimer's Disease: Lessons Learned and AppliedJames E Galvin
Neurology|September 12, 2007
Pass the grain; spare the brainJames E Galvin
Alzheimer Disease and Associated Disorders|November 30, 2006
Cognitive change in Parkinson diseaseJames E Galvin
Journal of the American Medical Directors Association|May 12, 2009
When a tremor is not just a tremor: cognitive and functional decline in essential tremor, a more complex disorder than we thoughtJames E Galvin
Neurology|April 10, 2015
Comment: Too much of a good thing may still be good for your brainJames E Galvin
Pageof 29

Showing results (1-10 of 286) with videos related to

Sort By:
Pageof 29
Prion|December 18, 2010
Dementia screening, biomarkers and protein misfolding: Implications for public health and diagnosisJames E Galvin
Acta Neuropathologica|June 23, 2006
Interaction of alpha-synuclein and dopamine metabolites in the pathogenesis of Parkinson's disease: a case for the selective vulnerability of the substantia nigraJames E Galvin
Continuum (Minneapolis, Minn.)|December 2, 2024
Lewy Body DementiaJames E Galvin
Archives of Neurology|September 17, 2003
Dementia with Lewy bodiesJames E Galvin
Alzheimer'S & Dementia (Amsterdam, Netherlands)|September 26, 2015
IMPROVING THE CLINICAL DETECTION OF LEWY BODY DEMENTIA WITH THE LEWY BODY COMPOSITE RISK SCOREJames E Galvin
Journal of the American Geriatrics Society|August 3, 2017
Prevention of Alzheimer's Disease: Lessons Learned and AppliedJames E Galvin
Neurology|September 12, 2007
Pass the grain; spare the brainJames E Galvin
Alzheimer Disease and Associated Disorders|November 30, 2006
Cognitive change in Parkinson diseaseJames E Galvin
Journal of the American Medical Directors Association|May 12, 2009
When a tremor is not just a tremor: cognitive and functional decline in essential tremor, a more complex disorder than we thoughtJames E Galvin
Neurology|April 10, 2015
Comment: Too much of a good thing may still be good for your brainJames E Galvin
Pageof 29